JASON EHRLICH - 24 Jun 2023 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Role: Chief Medical Officer and Chief Development Officer
Signature: /s/ David Peinsipp, Attorney-in-Fact for Jason Ehrlich
Issuer symbol: KOD
Transactions as of: 24 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2023, 17:35:28 UTC
Previous filing: 16 Jun 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KOD	Stock Option (Right to Buy)	Award	$0	+207,500		$0.000000	207,500	24 Jun 2023	Common Stock	207,500	$7.24	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Content

One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Remarks:

Chief Medical Officer and Chief Development Officer